FWP
ABBV icon

Flatrock Wealth Partners’s AbbVie ABBV Stock Holding History

Flatrock Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Buy
+942
New +$203K 0.09% 146
2026
Q1 		– Sell
-880
Closed -$201K – 167
2025
Q4 		$201K Buy
+880
New +$200K 0.1% 159

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Flatrock Wealth Partners's ABBV Position: Q2 2026 in Review

Flatrock Wealth Partners opened a new position in AbbVie (ABBV) in Q2 2026: 942 shares worth $237K. The stake represents 0.09% of the portfolio and ranks #146 among its holdings. This is a return to the name: Flatrock Wealth Partners previously reported a position in ABBV as recently as Q4 2025.

Flatrock Wealth Partners first reported a position in ABBV in Q4 2025 and has held it in 2 quarters since. 4,227 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Flatrock Wealth Partners held 942 shares of AbbVie worth $237K as of Q2 2026.
  • AbbVie was a new Flatrock Wealth Partners position in Q2 2026.
  • AbbVie made up 0.09% of Flatrock Wealth Partners's portfolio in Q2 2026, its #146 holding.
  • Flatrock Wealth Partners first reported a position in AbbVie in Q4 2025 and has held it in 2 quarters since.
  • 4,227 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Flatrock Wealth Partners's 13F filing for Q2 2026, filed 14 Aug 2026.